Two Sigma Advisers
FRLN

Two Sigma Advisers’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Two Sigma Advisers’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-813
Closed -$11K – 2778
2022
Q2 		$11K Sell
813
-780
-49% -$10K ﹤0.01% 2588
2022
Q1 		$27K Buy
+1,593
New +$29.6K ﹤0.01% 2644

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers's FRLN Position: Q3 2022 in Review

Two Sigma Advisers sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q3 2022, closing a stake of 813 shares — an estimated $11K sold.

Two Sigma Advisers first reported a position in FRLN in Q1 2022 and held it in 2 quarters. The position peaked at $27K in Q1 2022. 14 funds tracked by Wall St. Rank hold FRLN as of Q3 2022.

  • Two Sigma Advisers reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 813 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q3 2022, an estimated $11K.
  • Two Sigma Advisers first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q1 2022 and held it in 2 quarters.
  • Two Sigma Advisers's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $27K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.